Australian Institute of Health and Welfare (2022) Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data, AIHW, Australian Government, accessed 23 March 2023.
Australian Institute of Health and Welfare. (2022). Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data. Retrieved from https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data. Australian Institute of Health and Welfare, 18 February 2022, https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Australian Institute of Health and Welfare. Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2023 Mar. 23]. Available from: https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
Australian Institute of Health and Welfare (AIHW) 2022, Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme: quarterly data, viewed 23 March 2023, https://www.aihw.gov.au/reports/health-care-quality-performance/impacts-of-covid19-mbs-pbs-quarterly-data
PDF | 567Kb
This website needs JavaScript enabled in order to work correctly; currently it looks like it is disabled. Please enable JavaScript to use this website as intended.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.